Yuewen Song

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

Jianxiang Wang, Xiaolong Zhang, M. Hao, 2019, Journal of Hematology & Oncology.

An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma

Y. Zhen, Ming Yang, D. Xiong, 2019, Front. Oncol..

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Jianxiang Wang, M. Hao, D. Xiong, 2021, Frontiers in Oncology.